(Post-pandemic Era)-Global Oligonucleotide Therapeutics Market Outlook-by Major Company, Regions, Type, Application and Segment Forecast, 2015-2026

Report ID: 247139 | Published Date: Jan 2025 | No. of Page: 104 | Base Year: 2024 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
Table of Contents

Global Oligonucleotide Therapeutics Market Outlook-by Major Company, Regions, Type, Application and Segment Forecast, 2015-2026
1 Market Scope Oligonucleotide Therapeutics
    1.1  Oligonucleotide Therapeutics Market Snapsshot
        1.1.1 Major Companies Overview
        1.1.2 Market Concentration
        1.1.3 Market Share & Six-Year Compound Annual Growth Rate of Major Market (CAGR)
2 Global Oligonucleotide Therapeutics Industry Analysis
    2.1  Sector Breakdown Assessment, 2015-2026
    2.2  Market Assessment by Type
    2.3  Market Size Analysis and Forecast, by Application
3 China Oligonucleotide Therapeutics Market Estimates & Forecasts
    3.1  China Oligonucleotide Therapeutics Market by Sector, 2015-2026
    3.2  China Oligonucleotide Therapeutics Market by Application, 2015-2026
4 EU Oligonucleotide Therapeutics Market Estimates & Forecasts
    4.1  EU Oligonucleotide Therapeutics Market by Sector, 2015-2026
    4.2  EU Oligonucleotide Therapeutics Market by Application, 2015-2026
5 USA Oligonucleotide Therapeutics Market Estimates & Forecasts
    5.1  USA Oligonucleotide Therapeutics Market by Sector, 2015-2026
    5.2  USA Oligonucleotide Therapeutics Market by Application, 2015-2026
6 Japan Oligonucleotide Therapeutics Market Estimates & Forecasts
    6.1  Japan Oligonucleotide Therapeutics Market by Sector, 2015-2026
    6.2  Japan Oligonucleotide Therapeutics Market by Application, 2015-2026
7 India Oligonucleotide Therapeutics Market Estimates & Forecasts
    7.1  India Oligonucleotide Therapeutics Market by Sector, 2015-2026
    7.2  India Oligonucleotide Therapeutics Market by Application, 2015-2026
8 Southeast Asia Oligonucleotide Therapeutics Market Estimates & Forecasts
    8.1  Southeast Asia Oligonucleotide Therapeutics Market by Sector, 2015-2026
    8.2  Southeast Asia Oligonucleotide Therapeutics Market by Application, 2015-2026
9 South America Oligonucleotide Therapeutics Market Estimates & Forecasts
    9.1  South America Oligonucleotide Therapeutics Market by Sector, 2015-2026
    9.2  South America Oligonucleotide Therapeutics Market by Application, 2015-2026
10 Value Chain (Impact of COVID-19)
    10.1 Oligonucleotide Therapeutics Value Chain Analysis
        10.1.1 Downstream
    10.2 COVID-19 Impact on this Industry
        10.2.1 Industrial Policy Issued Under the Epidemic Situation
    10.3 Driver
    10.4 Opportunity

11 Competitive Analysis
    11.1 PCI Biotech
        11.1.1 Key Information
        11.1.2 Service/Solution Introduction
        11.1.3 Financials
        11.1.4 Business Dynamics
    11.2 SomaGenics
        11.2.1 Key Information
        11.2.2 Service/Solution Introduction
        11.2.3 Financials
        11.2.4 Business Dynamics
    11.3 ContraVir
        11.3.1 Key Information
        11.3.2 Service/Solution Introduction
        11.3.3 Financials
        11.3.4 Business Dynamics
    11.4 Alnylam
        11.4.1 Key Information
        11.4.2 Service/Solution Introduction
        11.4.3 Financials
        11.4.4 Business Dynamics
    11.5 Regulus Therapeutics
        11.5.1 Key Information
        11.5.2 Service/Solution Introduction
        11.5.3 Financials
        11.5.4 Business Dynamics
    11.6 Ionis Pharmaceuticals
        11.6.1 Key Information
        11.6.2 Service/Solution Introduction
        11.6.3 Financials
        11.6.4 Business Dynamics
    11.7 Gilead
        11.7.1 Key Information
        11.7.2 Service/Solution Introduction
        11.7.3 Financials
        11.7.4 Business Dynamics
    11.8 Santaris
        11.8.1 Key Information
        11.8.2 Service/Solution Introduction
        11.8.3 Financials
        11.8.4 Business Dynamics
    11.9 InteRNA
        11.9.1 Key Information
        11.9.2 Service/Solution Introduction
        11.9.3 Financials
        11.9.4 Business Dynamics
    11.10 miRage
        11.10.1 Key Information
        11.10.2 Service/Solution Introduction
        11.10.3 Financials
        11.10.4 Business Dynamics
    11.11 Biogen
    11.12 Merck
    11.13 Pfizer
12 Research Conclusion



List of Tables and Figures

    Table Revenue (Million USD) of Major Players (2015-2020)
    Figure Oligonucleotide Therapeutics Revenue Market Share of Top 5 Players
    Table Market Share & CAGR of Major Market (2021-2026)
    Figure Regional Market Share in Terms of Revenue (2019 - 2020)
    Table CAGR in Terms of Revenue of Each Type (2015-2026)
    Table Global Oligonucleotide Therapeutics Revenue (Million USD) by Type (2015-2026)
    Figure Global Oligonucleotide Therapeutics Revenue (Million USD) and Growth Rate (2015-2026)
    Figure Global Oligonucleotide Therapeutics Revenue Market Share (%) by Type (2019 – 2020)
    Figure Market Assessment by Type
    Table Historical & Forecast Oligonucleotide Therapeutics Different Application Field Revenue (Million USD)
    Table China Oligonucleotide Therapeutics Market Estimates & Forecasts by Sector (2015-2026)
    Figure China Oligonucleotide Therapeutics Revenue (Million USD) and Growth Rate (2015-2026)
    Figure Market Assessment by Type (2019-2020)
    Table Historical & Forecast Oligonucleotide Therapeutics Different Application Field Revenue (Million USD)
    Figure Different Application Field Revenue Market Share (%) (2019 – 2020)
    Table US Oligonucleotide Therapeutics Market Estimates & Forecasts by Sector (2015-2026)
    Figure US Oligonucleotide Therapeutics Revenue (Million USD) and Growth Rate (2015-2026)
    Figure Market Assessment by Type (2019-2020)
    Table Historical & ForecastOligonucleotide TherapeuticsDifferent Application Field Revenue (Million USD)
    Figure Different Application Field Revenue Market Share (%) (2019 – 2020)
    Table Europe Oligonucleotide Therapeutics Market Estimates & Forecasts by Sector (2015-2026)
    Figure Europe Oligonucleotide Therapeutics Revenue (Million USD) and Growth Rate (2015-2026)
    Figure Market Assessment by Type (2019-2020)
    Table Historical & Forecast Oligonucleotide Therapeutics Different Application Field Revenue (Million USD)
    Figure Different Application Field Revenue Market Share (%) (2019 – 2020)
    Table Japan Oligonucleotide Therapeutics Market Estimates & Forecasts by Sector (2015-2026)
    Figure Japan Oligonucleotide Therapeutics Revenue (Million USD) and Growth Rate (2015-2026)
    Figure Market Assessment by Type (2019-2020)
    Table Historical & Forecast Oligonucleotide Therapeutics Different Application Field Revenue (Million USD)
    Figure Different Application Field Revenue Market Share (%) (2019 – 2020)
    Table Southeast Asia Oligonucleotide Therapeutics Market Estimates & Forecasts by Sector (2015-2026)
    Figure Southeast Asia Oligonucleotide Therapeutics Revenue (Million USD) and Growth Rate (2015-2026)
    Figure Market Assessment by Type (2019-2020)
    Table Historical & Forecast Oligonucleotide Therapeutics Different Application Field Revenue (Million USD)
    Figure Different Application Field Revenue Market Share (%) (2019 – 2020)
    Table South America Oligonucleotide Therapeutics Market Estimates & Forecasts by Sector (2015-2026)
    Figure South America Oligonucleotide Therapeutics Revenue (Million USD) and Growth Rate (2015-2026)
    Figure Market Assessment by Type (2019-2020)
    Table Historical & Forecast Oligonucleotide Therapeutics Different Application Field Revenue (Million USD)
    Figure Different Application Field Revenue Market Share (%) (2019 – 2020)
    Figure Value Chain Structure of Oligonucleotide Therapeutics
    Table Value Chain
    Table Key Downstream Customer in Each Application Field
    Table Industry News List of Oligonucleotide Therapeutics
    Table PCI Biotech Key Information
    Table Oligonucleotide Therapeutics Revenue (Million USD) of PCI Biotech (2015-2020)
    Figure PCI Biotech Service/Solution Introduction
    Table SomaGenics Key Information
    Table Oligonucleotide Therapeutics Revenue (Million USD) of SomaGenics (2015-2020)
    Figure SomaGenics Service/Solution Introduction
    Table ContraVir Key Information
    Table Oligonucleotide Therapeutics Revenue (Million USD) of ContraVir (2015-2020)
    Figure ContraVir Service/Solution Introduction
    Table Alnylam Key Information
    Table Oligonucleotide Therapeutics Revenue (Million USD) of Alnylam (2015-2020)
    Figure Alnylam Service/Solution Introduction
    Table Regulus Therapeutics Key Information
    Table Oligonucleotide Therapeutics Revenue (Million USD) of Regulus Therapeutics (2015-2020)
    Figure Regulus Therapeutics Service/Solution Introduction
    Table Ionis Pharmaceuticals Key Information
    Table Oligonucleotide Therapeutics Revenue (Million USD) of Ionis Pharmaceuticals (2015-2020)
    Figure Ionis Pharmaceuticals Service/Solution Introduction
    Table Gilead Key Information
    Table Oligonucleotide Therapeutics Revenue (Million USD) of Gilead (2015-2020)
    Figure Gilead Service/Solution Introduction
    Table Santaris Key Information
    Table Oligonucleotide Therapeutics Revenue (Million USD) of Santaris (2015-2020)
    Figure Santaris Service/Solution Introduction
    Table InteRNA Key Information
    Table Oligonucleotide Therapeutics Revenue (Million USD) of InteRNA (2015-2020)
    Figure InteRNA Service/Solution Introduction
    Table miRage Key Information
    Table Oligonucleotide Therapeutics Revenue (Million USD) of miRage (2015-2020)
    Figure miRage Service/Solution Introduction
    Table Biogen Key Information
    Table Oligonucleotide Therapeutics Revenue (Million USD) of Biogen (2015-2020)
    Figure Biogen Service/Solution Introduction
    Table Merck Key Information
    Table Oligonucleotide Therapeutics Revenue (Million USD) of Merck (2015-2020)
    Figure Merck Service/Solution Introduction
    Table Pfizer Key Information
    Table Oligonucleotide Therapeutics Revenue (Million USD) of Pfizer (2015-2020)
    Figure Pfizer Service/Solution Introduction
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
-Global Oligonucleotide Therapeutics Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
-Global Oligonucleotide Therapeutics Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
-Global Oligonucleotide Therapeutics Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports